摘要:
简要介绍已广泛用于临床的^32P，^89Sr，^90Y，^103Pd，^125I，^131I，^137Cs，^153Sm，^186Re，^188Re，^192Ir和具有很大潜在使用可能性的^64Cu，^67Cu，^67Ga，^86Y，^105Rh，^111In，^114mIn，^124I，^149Pm，^166Ho，^169Yb，^177Lu，^211At，^213Bi，^225Ac 26个放射性核素利用反应堆或加速器或衰变的55种不同途径产生的核数据的测量、理论计算及数据可靠性的初步评价，以改善其在诊断和治疗医用中的安全性、有效性和科学性。The nuclear data measurements and preliminary evaluation as well as alculation for established and emerging 26 radionuclides produced in 55 ways by using reactor or accelerator or decay are briefly introduced in order to keep the safety and validity in medical therapeutic applications. The 11 established radionuclides are ^32P,^89Sr,^90Y,^103Pd,^125I,^131I,^137Cs,^153Sm,^186Re,^188Re,^192Ir and the 15 emerging radionuclides are 64Cu,^67Cu,^67Ga,^86Y,^105Rh,^111In,^114mIn,^124I,^149Pm,^166Ho,^169Yb,^177Lu,^211At,^213Bi,^225Ac.
关键词:
-
医用同位素 /
-
核数据 /
-
测量 /
-
评价
Abstract:
The nuclear data measurements and preliminary evaluation as well as alculation for established and emerging 26 radionuclides produced in 55 ways by using reactor or accelerator or decay are briefly introduced in order to keep the safety and validity in medical therapeutic applications. The 11 established radionuclides are ^32P,^89Sr,^90Y,^103Pd,^125I,^131I,^137Cs,^153Sm,^186Re,^188Re,^192Ir and the 15 emerging radionuclides are 64Cu,^67Cu,^67Ga,^86Y,^105Rh,^111In,^114mIn,^124I,^149Pm,^166Ho,^169Yb,^177Lu,^211At,^213Bi,^225Ac.
点击查看大图
下载:
甘公网安备 62010202000723号